Showing posts with label drug shortage. Show all posts
Showing posts with label drug shortage. Show all posts

Wednesday, September 19, 2012

Drug Information at the University of Michigan

Posted by Alison Van Kampen at Wednesday, September 19, 2012

Well, rotation number 3 is over, and I had a blast.  Most people will tell you before P4 year starts that Drug Information is a boring rotation, but I must beg to disagree.  I found this to be a really fun rotation that really suited my personality. 

The environment was very low key, which I like, and it didn't hurt that we had lots of space to work as opposed to being crammed down in B2 and fighting to find an available computer.  It also helped that all of the people in the Drug Information Service were great to work with (and I'm not just saying this because I know that they will be reading this post).  My primary preceptor was Dr. Stumpf and I also spent a lot of time with Dr. Bazzi, Dr. Dasse, and Dr. Sweet.  In addition, my fellow student, Matt Perez, and I spent a lot of time with the new resident as wekk. Everyone was very nice, they were helpful when I worked on projects and answered question, and they gave some pretty sound advice for the future.

I found the tasks and projects that we were assigned to be helpful, interesting, and often challenging.  Everyday we were responsible for taking a phone shift.  On the phone shift we would take calls from various people regarding unusual drug questions.  Questions would come in from everyone from physicians, pharmacy faculty, nurses, outpatient pharmacies, and lay-people. The majority of questions had to do with stability of a drug that was left out of the refrigerator (which often resulted in a long call to the manufacturer) but other questions were very interesting and required extensive research.  Here are just a few:

Is it safe to use sedative hypnotics in a patient that has insomnia related to Lewy Body Dementia? and if so, which ones?

Why is it that for all SSRIs, increased risk of bleeding is listed as an interaction with Clopidogrel, but fluoxetine has the added interaction of decreased efficacy of fluoxetine? What is different about fluoxetine?

Should a woman taking medications that compromise her immune system avoid contact with her grandchildren who recently received a live varicella vaccine? and if so for how long?

Are there any concerns, other than lack of efficacy, for a 14 month old patient that was being administered expired CellCept for the past 2 months?

In addition to answering these questions, we also had small projects like filling out MedWatch forms, learning about and determining the pros and cons of various sources of information (there are way more out there than you can imagine), finding ways to critically evaluate journal articles and the statistics they publish, and attending meetings at the hospital.  

We had two larger projects as well.  One was writing a newsletter article, mine was about the possible association between maternal use of SSRIs during pregnacy and Persistent Pulmonary Hypertesion of the Newborn, which was pretty cool.  The other large project was creating and delivering a P&T presentation on a new drug to the Drug Information staff.  This was exciting because I got to research and learn everything about a new drug, Carfilzomib, and learn more about the disease state that it treats, multiple myeloma.

Overall, I really liked this rotation.  There was very little patient interaction, which was good and bad.  Also because I'm not good at being put on the spot, I really liked that I was able to thoroughly research my answer to a question before delivering an answer. AND I was able to learn a lot of interesting and unsusal things about drugs (interesting and unusual has always been very attractive to me).  I would definitely recommend this site to anyone for their Drug Information Rotation.

Tuesday, October 25, 2011

It's Not Boring, I Swear.

Posted by Matthew Lewis at Tuesday, October 25, 2011

Hello Readers.

I'm already in the groove for my newest rotation, which is drug info. This is my second rotation in the Veteran's Affair group of hospitals, but there is a huge difference between the hospitals, and I think that is because of financial support. For example, the Detroit VA does not have a residency program but Ann Arbor (and Battle Creek) do.

[As a side note on residencies, several students from my class hope to be placed in the VA system, but I've been told that there aren't any residencies available at the Ann Arbor VA site this year. This situation isn't unique to VA as the demand for pharmacy residencies continues to outpace the supply
nationwide. That means increasingly intense competition for limited slots. Michigan has one of the highest pharmacy residency placement rates in the country, but being a Michigan PharmD does not automatically make you the preferred candidate for a residency. Landing a residency still comes down to polished interviewing skills and an ability to package your talents in ways that make you stand out from the crowd.]

Back to the story at hand. As I mentioned, my current rotation is drug info. My preceptor, Dr. Ed Lehaie is a great guy and was recognized as preceptor of the year for 1999. The first day was all about getting paperwork in and computer access. I even answered some questions. Today, I answered a few more questions, particularly on replacements for the pain medication fentanyl because there is a drug shortage looming on the horizon. First, I did not even realize there were other drugs in the fentanyl family, so learning about those was interesting. I compared onsets and found appropriate doses through literature searches for sufentanil, remifentanil, and alfentanil. Finally, I did a little cost analysis.

You may have heard about drug shortages in the news, since they have gotten so bad people are dying from not getting proper medications on time. Part of drug information's job is to figure out how to work around these shortages. The other major part of drug information's job is to ... well, dispense drug information. This is usually in the form of approving medication requests that are off-label or extremely costly, such as cancer medications. We will also present new drugs and new research to our pharmacy and therapeutics (P&T) committee, where they can discuss what additional restrictions they want to place on drugs. VA P&T committees are quite different from normal P&Ts, in that each hospital has to follow the nationally mandated formulary decided upon by the national P&T. The local hospitals can only further restrict use.

That's the nuts and bolts of this rotation. I'm definitely going to be getting some weird questions, so I'll keep in touch to share them all.